Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

Food Aversions on GLP-1s: What the Research Shows

What GLP-1 research says about appetite, taste and food preference, what it cannot explain about specific aversions, and when eating needs a review.

Written by — editorial research, not medical advice
On this page

Food preference is not the same as appetite

Eating less and finding a particular food unappealing are different experiences. I would ask which one is making meals difficult before choosing a solution. Less hunger, nausea after a meal, an altered taste and an inability to tolerate a texture can all sound like “I can’t eat that anymore,” but the practical questions are not identical.

A list from someone else’s kitchen, or even a roundup of women’s side effects, cannot establish a universal pattern or tell me why my own appetite has changed. So I would not assume chicken, eggs or coffee becomes impossible for everyone on a GLP-1, nor promise that a particular food returns after three months.

What has actually been measured

A randomized crossover study of 30 people treated with semaglutide measured appetite, energy intake and food preference over twelve weeks. It found less hunger and fewer cravings, together with a lower relative preference for fatty, energy-dense foods1. That supports an effect on food-related responses, rather than a theory that every change is imagined.

It does not establish that all participants developed aversions to the same foods. It also does not prove that a preference change is an allergy, explain why a particular texture becomes difficult, or provide a recovery schedule. I would keep those gaps visible rather than stretch the trial to match a specific anecdote.

A systematic review of randomized trials also examined appetite, gastric emptying, taste and food preference2. The authors emphasized the need for larger and longer studies. I would read that as evidence that these questions are being investigated, not as a complete map of what any individual will want to eat.

The digestive explanation has limits too

GLP-1-based medicines can delay gastric emptying, and a clinical review describes how that effect varies across drugs, exposure and individuals3. That may be relevant when meals feel uncomfortable. It does not establish that a dense piece of chicken necessarily stays for a particular number of hours or that the body has learned to reject it.

I would describe the symptom itself: does the food taste wrong, cause nausea, feel difficult to swallow or leave discomfort after eating? Those details help a clinician decide what needs assessment. Calling everything an expected aversion can hide a different problem.

Keeping meals workable without inventing a cure

If intake has become difficult, I would discuss realistic alternatives with the clinician or dietitian. The useful question is how to meet nutrition needs with foods and textures I can manage, rather than how to force a particular meal because it appeared in a diet plan.

My options to discuss might include different preparations, smaller portions or other protein-containing foods. I would consider allergies, dietary restrictions, medical conditions and what is actually affordable before treating any list as advice for everyone. A drink is not automatically a complete substitute for meals, and a food that is easy for someone else may still be difficult for me.

I would change one thing at a time where practical and note whether it helps. That is different from claiming a certain texture cured nausea or that repeatedly retrying a food guarantees it will return. The point is to give the care team useful observations without making eating into an endurance test.

When I would raise it promptly

Do mention it if you are struggling to eat enough at all, or if the list keeps growing rather than shifting. I would explain whether fluids are also becoming difficult and whether symptoms are worsening, rather than wait until the next automatic refill. A shrinking menu is different from “chicken is out,” and it is worth a conversation with whoever prescribes for you.

I would want access to someone who can review eating difficulties alongside the other side effects worth reporting. I would not expect every food preference to follow the same story, and a good reviewer should not need mine to.

Frequently asked questions

Why can I not eat chicken on a GLP-1?

Studies show changes in appetite and some food preferences, but they do not establish a universal chicken aversion or a specific explanation for your symptoms. Describe whether the issue is taste, texture, nausea, swallowing or discomfort.

Do food aversions go away?

The cited evidence does not provide an individual recovery timetable. If aversions persist, broaden or interfere with adequate eating, discuss them with the prescriber rather than assume a particular food must return.

How do I get enough protein if meat is out?

Ask a clinician or dietitian about alternatives that fit your health, dietary restrictions and tolerable textures. Different preparations or protein-containing foods may be options, but a general list is not a personalized nutrition plan.

When is this worth mentioning to my clinician?

If you are struggling to eat enough overall, or if the list of impossible foods keeps growing rather than shifting around. That is different from a few specific things dropping off, and it is worth raising with whoever prescribes for you.

References

  1. Blundell J, Finlayson G, Axelsen M, Flint A, et al. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/28266779/
  2. Aldawsari M, Almadani FA, Almuhammadi N, Algabsani S, et al. (2023). The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials. Diabetes, Metabolic Syndrome and Obesity. https://pubmed.ncbi.nlm.nih.gov/36890965/
  3. Jalleh RJ, Plummer MP, Marathe CS, et al. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. The Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/39418085/

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.